ArticleThoracic cancer2019

Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer.

Ryota Shibaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.